Related Experiment Video

Updated: Nov 1, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis

Chuan Zhang1,2, Dan Dang3, Lele Cong1

  • 1Department of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.

Cancer Medicine
|June 23, 2021
PubMed
Abstract

Insights

This study identifies key genes like IL2RA, IL2RG, IFNG, and IL7R as crucial drivers of melanoma metastasis. These findings highlight potential new therapeutic targets for treating this deadly skin cancer.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Melanoma is a deadly skin cancer with limited effective treatments.
  • Understanding melanoma metastasis mechanisms is critical for developing targeted therapies.

Purpose of the Study:

  • Identify hub genes involved in melanoma metastasis.
  • Elucidate molecular mechanisms driving melanoma progression.
  • Determine potential therapeutic targets for melanoma treatment.

Main Methods:

  • Analyzed RNA-seq data (mRNA, miRNA, lncRNA) from TCGA database to identify hub genes.
  • Validated hub genes using qRT-PCR in human melanoma tissues.
  • Investigated competing endogenous RNA interactions and signaling pathways.
  • Assessed immune cell abundance in the tumor microenvironment using CIBERSORTx.

Main Results:

  • Identified IL2RA, IL2RG, IFNG, and IL7R as hub genes associated with poor melanoma prognosis.
  • Discovered LINC02446, LINC01857, and LINC02384 as potential competing endogenous lncRNAs for IL2RA and IL7R.
  • The JAK-STAT signaling pathway was implicated in melanoma metastasis.
  • Elevated regulatory T-cell abundance was observed in metastatic melanoma, correlating with increased expression of identified hub genes.

Conclusions:

  • Elevated IL2RA, IL2RG, IL7R, and IFNG expression promotes melanoma metastasis by increasing regulatory T-cells via JAK-STAT signaling.
  • Specific lncRNAs may drive melanoma progression by modulating microRNA levels.
  • Molecules such as TNFRSF13B, LAG3, NRP1, ENTPD1, NT5E, CCL21, and CCR7 represent promising therapeutic targets for melanoma.
Keywords:
IL2RAIL7RINFGTNFRSFlncRNAmelanomamiRNAregulatory T cell

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.7K
Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.8K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
790
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K